Encapsulated faecal microbiota transfer to target immune activation in patients with cirrhosis and ascites (TransImmune): protocol for a randomised, double-blind, Phase IIa, placebo-controlled trial.
- DOI
- 10.1136/bmjopen-2026-119299
- Published
- 2026 Aug 12
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2026-119299,
title = {Encapsulated faecal microbiota transfer to target immune activation in patients with cirrhosis and ascites (TransImmune): protocol for a randomised, double-blind, Phase IIa, placebo-controlled trial.},
author = {Große K and Haedge F and Fera C and Hecker J and Wienstroer J and Tsakmaklis A and Fichtner A and Treichel NS and Clavel T and Wirtz TH and Pabst O and Schuckelt R and Vehreschild MJ and Bruns T},
year = {2026},
journal = {BMJ open},
doi = {10.1136/bmjopen-2026-119299},
url = {https://doi.org/10.1136/bmjopen-2026-119299}
}RIS
TY - JOUR TI - Encapsulated faecal microbiota transfer to target immune activation in patients with cirrhosis and ascites (TransImmune): protocol for a randomised, double-blind, Phase IIa, placebo-controlled trial. AU - Große K AU - Haedge F AU - Fera C AU - Hecker J AU - Wienstroer J AU - Tsakmaklis A AU - Fichtner A AU - Treichel NS AU - Clavel T AU - Wirtz TH AU - Pabst O AU - Schuckelt R AU - Vehreschild MJ AU - Bruns T PY - 2026 JO - BMJ open DO - 10.1136/bmjopen-2026-119299 UR - https://doi.org/10.1136/bmjopen-2026-119299 ER -
APA
K, G., F, H., C, F., J, H., J, W., A, T., A, F., NS, T., T, C., TH, W., O, P., R, S., MJ, V., & T, B. (2026). Encapsulated faecal microbiota transfer to target immune activation in patients with cirrhosis and ascites (TransImmune): protocol for a randomised, double-blind, Phase IIa, placebo-controlled trial.. BMJ open. https://doi.org/10.1136/bmjopen-2026-119299
Source records
- pubmed · retrieved 2026-09-25T10:55:37.341Z